FMN is one of the two active coenzyme forms of riboflavin (FMN, FAD). Directly incorporable into flavoenzymes without the RFK-mediated phosphorylation step required for riboflavin. Theoretical advantage in RFK polymorphisms; clinical advantage over plain riboflavin is small.
Half-Life (t½)
PO: 1.1h
Dosing Guidelines
PO: Typical 23.3 mg (Range: 10â50 mg)
Target Organ Systems
musculoskeletal
Interactions
Riboflavin (synergistic): Same family â FMN is the activated form. No need to co-supplement; pick one.